Medication Management. Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015

Similar documents
Mood Disorders for Care Coordinators

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Intro to Concurrent Disorders

Aiming for recovery for patients with severe or persistent depression a view from secondary care. Chrisvan Koen

Depression: Assessment and Treatment For Older Adults

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

Major Depressive Disorder (MDD) in Children under Age 6

A Basic Approach to Mood and Anxiety Disorders in the Elderly

Oxleas CAMHS Dr Joanna Sales Clinical Director. Adolescent problems: Depression Deliberate Self Harm Early Intervention in Psychosis

Clinical Guideline for the Management of Bipolar Disorder in Adults

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Understanding Psychiatry & Mental Illness

Treatment Options for Bipolar Disorder Contents

MENTAL HEALTH DISEASE CLASSIFICATIONS

Major Depressive Disorder (MDD) in Children under Age 6

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care

MANAGING PERSONALITY DISORDERS on Women s PICU Dr Paola Rossin

Prescribing for people with a personality disorder. POMH-UK QIP 12b

Prescribing medications for people with a personality disorder A service evaluation of a community mental health team

CASE 5 - Toy & Klamen CASE FILES: Psychiatry

Medication management of anxiety & depression. Dr Katie Simpson GP Mental health lead East Berks CCG

Charles B. Nemeroff, M.D., Ph.D.

Relationship Between Mental Health Problems and Challenging Behaviour in People with Intellectual Disabilities

Suicide, Para suicide and Risk Assessment

Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)

Depression in adults: treatment and management

What is Schizophrenia?

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Review: Psychosocial assessment and theories of development from N141 and Psych 101

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES

Malaysian Healthy Ageing Society

Pharmacological Treatment of Anxiety & Depressive Disorders

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

Navigating Student Mental Health Issues

Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington. Approach for doing differential diagnosis of PTSD

POLYPHARMACY : FOR AND AGAINST NZMA GP CONFERENCE 2012 PSYCHOPHARMACOLOGY SERIES. Guna Kanniah Waikato Hospital

Suicide Spectrum Assessment and Interventions. Welcome to RoseEd Academy. Disclaimer

Objectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS

Mental Health and Sexual Health. John Green CNWL NHS Trust, St Mary s Hospital London, Imperial College London

The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability

HealthPartners Care Coordination Clinical Care Planning and Resource Guide EATING DISORDER

DIAGNOSTIC CRITERIA (ICD 10)

Chapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1%

How to Manage Anxiety


Borderline personality disorder: what role for medication?

Document Title Pharmacological Management of Generalised Anxiety Disorder

Management of a HIV-infected patient with a psychiatric disorder

ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN

Professor Tony Holland, Department of Psychiatry, University of Cambridge

Disclosures. Overview of Workshop. Objectives. Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

Managing Common Mental Health Problems

HealthyPlace s Introductory Guide to Bipolar Disorder. By Natasha Tracy

Practice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association

Drug History Zopiclone 3.75mg ON PRN (Review Overdue) Clozapine 50mg OM and 75mg ON (Prescribed by the mental health team)

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

ASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service

LIAISON PSYCHIATRY FOR OLDER PEOPLE

VO- PMHP Treatment Guideline 102: Electroconvulsive Therapy (ECT)

IDDT Fidelity Action Planning Guidelines

Perinatal Mental Health

Kaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System

The In-betweeners: What to do with problem gamblers with mental health problems. Neil Smith National Problem Gambling Clinic CNWL NHS Trust

Affective Disorders.

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario

Depression Disease Navigation

Margaret Oates Maternal Mental Health and Liaison Mental Health

Youth Mental Health Awareness JAMIE KURIGER RUTH LIEBOLD

Working with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers

DISEASES AND DISORDERS

Adult Mental Health Services applicable to Members in the State of Connecticut subject to state law SB1160

Depression: selective serotonin reuptake inhibitors

Antidepressants for treatment of depression.

Mood Disorders Workshop Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland

Achieve Remission in Adult Patients With Non-Psychotic Major Depressive Disorder: Algorithm

Mental Health Series for Perinatal Prescribers. Severe postpartum syndromes

Zero Suicide Pathway. Suicide Prevention Strategy The Gold Coast Mental Health and Specialist Service

4/29/2016. Psychosis A final common pathway. Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue

Benzodiazepines: risks, benefits or dependence

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

Psychotropic Medication

Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services

Treatment Algorithm Treatment Algorithm

Depression in children: identification and management of depression in children and young people in primary, community and secondary care

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

Anxiety Disorders: First aid and when to refer on

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child

Antidepressant Medication Therapy in Primary Care July 25, 2013

PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE

Managing Behavioural Problems in Patients with Learning Disabilities

I m in Crisis. Now what?

Charles B. Nemeroff, M.D., Ph.D.

Jennifer M. Lytle, M.D., M.P.H. Clinical Trials of the Rockies 3955 E. Exposition Avenue, Suite 100 Denver, CO Tel.

Abbreviated Class Review: Long-Acting Injectable Antipsychotics

Transcription:

Medication Management Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015 1

Medication Management Objectives: 1. Principles of psycho-pharmacology 2. Common mental health conditions 3. Frequent issues in general practice 4. Risks related to medication 5. Cases 2

Principles of psycho-pharmacology - Principle Diagnosis, Co-morbid conditions - Treatment options for the condition: Bio-Psycho-Social approach - Informed consent - Medication selection Evidence based, Treatment Guidelines Age, sex, body weight, special groups 3

Principles of psycho-pharmacology- cont. When are medication used? What is the optimal dose? What the maintenance dose? Monitoring of mental and physical state Regular risk assessment Failure to respond to treatment, Why? Discontinuation of medication 4

The phase of Treatment Subside acute symptoms Relieve symptoms Restore previous level of function (REHABILITATION) Maintain stabilization Prevent return of acute symptoms Continue Rx for the duration of the episode E.g. Depression 6/12 First Episode Psychosis 2 years Recurrent relapses- many yrs, lifelong Relapse prevention 5

Common mental health issues Mood disorders Anxiety disorders Psychotic disorders Drug and alcohol disorders Personality disorders 6

Cases and possible interventions: 1. Commencement of medication 2. Titration of medication 3. Change of medication 4. Combination of medications/ Poly-pharmacy 5. Interaction of medication 6. Interaction of medication and substances/ alcohol: 7. Non-adherence of medication 7

Commencement of medication Case 1: 45 year old professional, female, single, lives alone Diagnosis: severe OCD, no acute risks, affecting her work and social life, became unemployed due to ongoing symptoms and secondary depression Never treated with antidepressant medication, not willing to see a psychologist, but willing to see a psychiatrist Not happy to take antidepressants Group Discussion 8

Case 1, Management: Had initial assessment and provided treatment options. Fluctuated her insight, fear of medication side effects and questioning possible improvement. Took 3 months to convince her pharmacological treatment. Commence Paroxetine 10mg mane and titrate up to 20mg after few months. Tolerated side effects well, improved significantlymentally, socially, professionally. No relapses for the last 3 years. Take home message psycho-education ++++, provide options, engage, develop trust, support the patient to understand the nature of illness, titrate medication up slowly, monitor regularly 9

Titration of medication Case 2: 78 year old lady, lives with husband, previous psychiatric history +, no drug and alcohol history Diagnoses: Generalized Anxiety Disorder with secondary depression, Eating Disorder NOS, Cluster C Personality traits (dependent, avoidant, anxious) GP commenced Escitalopram 5mg mane few weeks ago, Zolpidem 10mg nocte 12 months ago Issues: extremely fearful of increasing the dose, slowly deteriorating for more than 2 years- physically, socially, psychologically, not safe at home, can not increase medication due to her fears Group Discussion 10

Case 2: Management: GP referred the patient to a private psych inpatient unit. Admitted to a private psychiatric unit, educated the patient and family, engage, assess regularly, titrated the dose of Escitalopram by 2.5mg increments up to 15mg at night, not developed any side effect, started reducing the dose of Zolpidem Incorporated CBT, regular day leave with the family and prepare for discharge Take home message- Psycho-education ++++, support the patient and family to understand the nature of illness, titrate slowly, monitor regularly Avoid long-term use of hypnotics/ Benzodiazepine Get specialist opinion early 11

Change of medication Case 3: 35 year old gentleman, single, stressed at work due to work load, on medical leave and subsequently lost his job. Diagnoses: Major Depressive Disorder, Cluster C personality traits Was on Mirtazapine 60mg nocte for few months, worsening depressive symptoms and suicidal ideation Mirtazapine was ceased abruptly and commenced Paroxetine 20mg mane Became extremely anxious and depressed, sleep disturbances, Emergency Dept, Crisis team involvement Group Discussion 12

Case 3: cont. Issues related to medication change: - Abrupt discontinuation of highest dose of Mirtazapine and commencement of Paroxetine - Possible short term use of Diazepam - Regular reviews Management: Regular MSEx, Reassurance, adding Diazepam. Later reduce and ceased diazepam Involvement of a clinical psychologist Take home message: educate the patient, involve family, wean of the medication, review the patient regularly, private admission +/-, involve Crisis Team 13

Interaction of medication and substances/ alcohol: Case 4: 68 year old businessman, lives with wife, adult children Diagnoses: Major Depressive Disorder, Alcohol Dependence, relationship difficulties, sexual dysfunction Issues: ongoing depressive symptoms for years, risk of suicide as father also committed suicide, Work long hours- 7 days a week Medication: Mirtazapine 90mg nocte, Venlafaxine XR 150mg mane, Diazepam 5-10mg PRN Group Discussion 14

Case 4, Management: Assessed regularly, educate patient and wife, treatment options explained (including Lithium Carbonate therapy as an adjunct) Counsel in relation to effects of alcohol ---- ceased alcohol use completely Regular phone discussions with the GP only one prescriber Cease Mirtazapine and diazepam Titrated up Venlafaxine XR 300mg mane Life style modifications: work (Mon-Fri), encourage to engage in his previous pleasure activities Significant improvement in all domains, no relapses Take home message: address alcohol and substance abuse, simplify medication regimen to minimize interaction, avoid poly-pharmacy, better communication bet therapists/ patient/ family, consider Lithium Carbonate 15

Non-adherence of medication Case 5: 30 year old, single man, lives alone, work 3-4 days a week, could not Diagnoses: Paranoid Schizophrenia, alcohol abuse Medication: Risperidone 3mg nocte, good response to medication when he takes them daily Issues: ongoing Persecutory delusions, alcohol abuse, poor adherence to medication, could not attend work regularly due to persecutory delusions, risk of harming others and self, risk of resistance to medication, emerging negative symptoms Group Discussion 16

Case 5, Plan of management: Psycho-education, Address alcohol abuse Engagement with the treatment plan, Introduce Webster/ Blister pack Commencement of Risperidone Consta (depot medication) fortnightly instead of oral Risperidone to improve medication adherence Take home message: Address non-adherence the medication, Treat co-morbid alcohol/ substance abuse, get specialist opinion in early phase of psychotic disorders to prevent negative symptoms, multiple relapses 17

Thank you. Dr Ajith Weeraman 18